Overview

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
It is believed that imiquimod 5% cream has the potential to be an effective treatment for actinic keratoses. The purpose of this study is to evaluate the duration of the effect of topical imiquimod 5% topical cream for the treatment of actinic keratoses.
Phase:
Phase 3
Details
Lead Sponsor:
University of British Columbia
Collaborators:
3M
Vancouver Coastal Health Research Institute
Treatments:
Imiquimod